Research Article

Clinical and Renal Biopsy Findings Predicting Outcome in Renal Thrombotic Microangiopathy: A Large Cohort Study from a Single Institute in China

Table 6

Comparisons of clinical, laboratory, and renal pathological data among patients with aHUS, pregnancy-associated TMA, and malignant hypertension.

aHUSPregnancy associated TMAMalignant hypertensionP value

Number of patients71461

Age (years)0.122
Gender (male : female)5 : 20 : 1455 : 6<0.001
Fever (%)02 (14.3)5 (8.2)0.534
Neurological abnormalities (%)1 (14.3)1 (7.1)2 (3.3)0.401
Liver involvement (%)07 (50)0<0.001
Heart involvement (%)001 (1.6)0.840
Hematuria (%)5 (71.4)10 (71.4)37 (60.7)0.677
Proteinuria (g/d)0.816
Albumin (g/L)0.239
Creatinine (mol/L)870.0 (671.0–1200)370.5 (78.5–602.8)560.0 (291.6–904.9)0.021
Hemoglobin (g/L)0.037
Platelet count (/L)0.004
Lactate dehydrogenase (IU/L)551 (266–1360)1156 (369–2762)216 (163–309)<0.001
Modified Rose score0.001
Acute renal TMA pathologic changes (%)5 (71.4)4 (28.6)7 (11.5)<0.001
Chronic renal TMA pathologic changes (%)5 (71.4)2 (14.3)58 (95.1)<0.001
Location of renal TMA pathologic changes
 G (%)04 (28.6)0<0.001
 A (%)2 (28.6)4 (28.6)60 (98.4)
 G and A (%)5 (71.4)6 (42.9)1 (1.6)

Notes: aHUS: atypical hemolytic uremic syndrome; G: glomeruli; A; artery/arteriole; G and A: glomeruli and artery/arteriole.